Albert B. Beckers

Liege, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 170 publications

Climate change and global pollution : endocrine consequences

Climate change and global pollution : endocrine consequences

Journal: Revue medicale de Liege

Published: June 08, 2026

Metyrapone-Associated Improvements in Health-Related Quality of Life in Cushing's Syndrome.

Metyrapone-Associated Improvements in Health-Related Quality of Life in Cushing's Syndrome.

Journal: European journal of endocrinology

Published: May 19, 2026

Genome architecture in endocrine diseases: X-Linked Acrogigantism (X-LAG) syndrome.

Genome architecture in endocrine diseases: X-Linked Acrogigantism (X-LAG) syndrome.

Journal: Annales d'endocrinologie

Published: May 08, 2026

Genome architecture in endocrine diseases: X-linked acrogigantism (X-LAG) syndrome.

Genome architecture in endocrine diseases: X-linked acrogigantism (X-LAG) syndrome.

Journal: Annales d'endocrinologie

Published: March 26, 2026

A 12,000-Year-Old Case of NPR2-Related Acromesomelic Dysplasia.

A 12,000-Year-Old Case of NPR2-Related Acromesomelic Dysplasia.

Journal: The New England journal of medicine

Published: January 28, 2026

Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5).

Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5).

Journal: Pituitary

Published: October 01, 2025

Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE.

Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE.

Journal: NPJ genomic medicine

Published: July 10, 2025

Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE.

Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE.

Journal: medRxiv : the preprint server for health sciences

Published: July 09, 2025

Consensus on acromegaly therapeutic outcomes: an update.

Consensus on acromegaly therapeutic outcomes: an update.

Journal: Nature reviews. Endocrinology

Published: June 30, 2025

Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT).

Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT).

Journal: European journal of endocrinology

Published: June 02, 2025

SIADH as an uncommon presentation of olfactory neuroblastoma: a case-based overview.

SIADH as an uncommon presentation of olfactory neuroblastoma: a case-based overview.

Journal: Endocrine oncology (Bristol, England)

Published: February 27, 2025

Expanding the phenotype of multiple endocrine neoplasia type 5 (MEN5): Pituitary gigantism, myelolipoma and familial pheochromocytoma due to a germline pathogenic MAX variant.

Expanding the phenotype of multiple endocrine neoplasia type 5 (MEN5): Pituitary gigantism, myelolipoma and familial pheochromocytoma due to a germline pathogenic MAX variant.

Journal: Endocrine

Published: December 13, 2024

Showing 1-12 of 170

Last Updated: 09/26/2026